• Ensysce Biosciences Announces Closing of Merger firstwordpharma
    July 01, 2021
    Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ: ENSC) (OTC: ENSCW) today announced that it has closed its previously announced merger with Leisure Acquisition Corp. ("LACQ").
  • “At Home Coronavirus Pill” to Advance to Phase 2 Clinical Development americanpharmaceuticalreview
    May 08, 2021
  • Recro, Ensysce Expand Development and Manufacturing Partnership contractpharma
    April 16, 2021
PharmaSources Customer Service